Rang	Name	Position
1	Dr. Christopher R. Anzalone Ph.D.	Chairman, CEO & President
2	Mr. Daniel J. Apel	Chief Financial Officer
3	Mr. Patrick O'Brien J.D., PharmD	COO & Secretary
4	Dr. James C. Hamilton M.D., MBA	Chief Medical Officer and Head of R&D
5	Dr. Mark M. Davis Ph.D.	Founder and Founder & Director of Insert Therapeutics Inc & Calando
6	Dr. Tao Pei Ph.D.	Chief Scientific Officer
7	Dr. Vincent Anzalone CFA	Head of Investor Relations & VP
8	Mr. Howard Lovy	Director of Communications
9	Dr. Bruce D. Given M.D.	Chief Medical Scientist
10	Dr. Mark Seefeld	Head of Toxicology & VP

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	10,50%	0,89 Mrd. USD
2	venBio Select Advisor LLC	8,04%	0,68 Mrd. USD
3	FMR Inc	5,69%	0,48 Mrd. USD
4	Vanguard Portfolio Management, LLC	4,50%	0,38 Mrd. USD
5	Vanguard Capital Management, LLC	4,33%	0,37 Mrd. USD
6	State Street Corp	4,03%	0,34 Mrd. USD
7	NORGES BANK	2,76%	0,24 Mrd. USD
8	Amvescap Plc.	2,75%	0,23 Mrd. USD
9	Geode Capital Management, LLC	2,50%	0,21 Mrd. USD
10	Fred Alger Management, LLC	2,34%	0,20 Mrd. USD
11	Baker Bros Advisors LP	1,41%	0,12 Mrd. USD
12	Siren, L.L.C.	1,21%	0,10 Mrd. USD
13	Vestal Point Capital LP	1,12%	0,10 Mrd. USD
14	HHG PLC	1,02%	0,09 Mrd. USD
15	Deerfield Management Co	0,98%	0,08 Mrd. USD
16	First Trust Advisors L.P.	0,96%	0,08 Mrd. USD
17	Driehaus Capital Management LLC	0,96%	0,08 Mrd. USD
18	Jupiter Topco LLC	0,86%	0,07 Mrd. USD
19	Northern Trust Corp	0,84%	0,07 Mrd. USD
20	Dimensional Fund Advisors, Inc.	0,84%	0,07 Mrd. USD